Cancer-associated retinopathy patients possess recoverin-specific cytotoxic T lymphocytes (CTLs) in the peripheral blood, which can recognize aberrantly expressing recoverin in cancer cells (109, 111). This evidence concerns the gene RCVRN and cancer.